APA (7th ed.) Citation

Gravina, G. L., Mancini, A., Colapietro, A., Monache, S. D., Sferra, R., Pompili, S., . . . Festuccia, C. (2019). The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine Models. MDPI AG.

Chicago Style (17th ed.) Citation

Gravina, Giovanni Luca, et al. The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine Models. MDPI AG, 2019.

MLA (8th ed.) Citation

Gravina, Giovanni Luca, et al. The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine Models. MDPI AG, 2019.